Find clinical trials for crohn's disease. Search for crohn's disease clinical trials in different cities and states across the United States.
Filter
1
Filter results
Results: 134
Active & Responsive
VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study
for
Crohn's Disease
Location: Sun City AZ, Kissimmee FL, Evanston IL, Iowa City IA,
Sponsor: Alimentiv Inc.
Sex: All
Age: 18+
Code: NCT06249555
Recruiting
Active & Responsive
Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
for
Crohns Disease
Location: Rochester MN, St Louis MO, Cleveland OH, Hamilton,
Sponsor: Alimentiv Inc.
Sex: All
Age: 18+
Code: NCT06670638
Recruiting
Active & Responsive
DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's Disease
for
Perianal Fistula Due to Crohn's Disease
Location: New York NY
Sponsor: Direct Biologics, LLC
Sex: All
Age: 18 - 70+
Code: NCT06918808
Phase2, Recruiting
Active & Responsive
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
Get alerts for new trials in your area by subscribing now
Active & Responsive
Treatment of Moderate to Severe Refractory Crohn's Disease
for
Crohns Disease
Location: Scottsdale AZ, Sacramento CA, San Francisco CA,
Sponsor: Tr1X, Inc.
Sex: All
Age: 18 - 65
Code: NCT06721962
Phase1, Phase2, Recruiting
Active & Responsive
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
for
Ulcerative Colitis (UC), Crohn's Disease (CD),
Location: Chapel Hill NC
Sponsor: University of North Carolina, Chapel Hill
Sex: All
Age: 18+
Code: NCT07237516
Recruiting
Active & Responsive
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
for
Crohn's Disease
Location: Los Angeles CA, Murrieta CA, Orange CA, Clearwater FL,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT06233461
Phase2, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: Dothan AL, Phoenix AZ, Sun City AZ, Garden Grove CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819878
Phase3, Recruiting
Active & ResponsiveNew
De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis
for
Crohn Disease (CD), Ulcerative Colitis (UC)
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre